Melola Discovery

← Melola Discovery

Jurnal Tanpa peringkat SINTA

Phenytoin: Clinical Use, Pharmacokinetics, Pharmacodynamics, Toxicology, Side Effects, Contraindication, and Drug Interactions

Journal of Science and Technology Research for Pharmacy · Vol. 2 No. 2 (2023) · hlm. 31–37

DOI
10.15294/jstrp.v2i2.69275
ISSN
2776-0685
Terbit
2023-07-28
Penerbit
Universitas Negeri Semarang
Bahasa
eng

Abstrak

Phenytoin is an antiepileptic drug derived from an organic compound called hydantoin. Phenytoin is an antiepileptic drug primarily used to treat seizures in people with epilepsy. Phenytoin works by targeting and blocking voltage-gated sodium channels in the nervous system, which helps reduce abnormal electrical activity in the brain that leads to seizures. Phenytoin can also be used to treat trigeminal neuralgia and ventricular tachycardia. Absorption of phenytoin depends on the mode of administration either peroral or parenteral. The distribution of phenytoin is affected by plasma protein binding. Phenytoin is metabolized primarily by liver enzymes, especially the cytochrome P450 enzyme system. Phenytoin excretion is influenced by the pH in the urine. Side effects of phenytoin use that can occur are sedation, hallucinations, fever, sedation, confusion, hallucinations, peripheral neuropathy, stevens-johnson syndrome, cardiovascular collapse, hypotension, purple glove syndrome, nystagmus, ataxia, nausea, coma, seizures, vomiting, hyperactivity, lethargy, fetal hydantoin syndrome (FHS), and megaloblastic anemia. Contraindications to the use of phenytoin are in someone with hypersensitivity to phenytoin or other hyndatoin, pregnant women, and lactating women. Oral phenytoin overdose causes neurotoxicity and parenteral phenytoin overdose causes cardiovascular toxicity. There is no specific antidote for phenytoin toxicity and the usual treatment is supportive care. There are various drugs that can interact with phenytoin to decrease or increase phenytoin levels.

Jaringan kolaborasi para penulis

5 penulis · 10 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/sju/index.php/JSTRP/oai, pertama di-harvest 5 Nov 2026, terakhir terlihat 8 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Phenytoin: Clinical Use, Pharmacokinetics, Pharmacodynamics, Toxicology, Side Effects, Contraindication, and Drug Interactions</dc:title>
	<dc:creator>Faturachman, Gavriel Fauzan</dc:creator>
	<dc:creator>Sari, Lolita Tiara</dc:creator>
	<dc:creator>Artanti, Naura</dc:creator>
	<dc:creator>Shakira, Shakira</dc:creator>
	<dc:creator>Zalikha, Tsabita Nafla</dc:creator>
	<dc:description xml:lang="en-US">&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Phenytoin is an antiepileptic drug derived from an organic compound called hydantoin. Phenytoin is an antiepileptic drug primarily used to treat seizures in people with epilepsy. Phenytoin works by targeting and blocking voltage-gated sodium channels in the nervous system, which helps reduce abnormal electrical activity in the brain that leads to seizures. Phenytoin can also be used to treat trigeminal neuralgia and ventricular tachycardia. Absorption of phenytoin depends on the mode of administration either peroral or parenteral. The distribution of phenytoin is affected by plasma protein binding. Phenytoin is metabolized primarily by liver enzymes, especially the cytochrome P450 enzyme system. Phenytoin excretion is influenced by the pH in the urine. Side effects of phenytoin use that can occur are sedation, hallucinations, fever, sedation, confusion, hallucinations, peripheral neuropathy, stevens-johnson syndrome, cardiovascular collapse, hypotension, purple glove syndrome, nystagmus, ataxia, nausea, coma, seizures,&amp;nbsp; vomiting, hyperactivity, lethargy, fetal hydantoin syndrome (FHS), and megaloblastic anemia. Contraindications to the use of phenytoin are in someone with hypersensitivity to phenytoin or other hyndatoin, pregnant women, and lactating women. Oral phenytoin overdose causes neurotoxicity and parenteral phenytoin overdose causes cardiovascular toxicity. There is no specific antidote for phenytoin toxicity and the usual treatment is supportive care. There are various drugs that can interact with phenytoin to decrease or increase phenytoin levels.</dc:description>
	<dc:publisher xml:lang="en-US">Universitas Negeri Semarang</dc:publisher>
	<dc:date>2023-07-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/sju/JSTRP/article/view/69275</dc:identifier>
	<dc:identifier>10.15294/jstrp.v2i2.69275</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Science and Technology Research for Pharmacy; Vol 2 No 2 (2022); 31-37</dc:source>
	<dc:source>2776-0685</dc:source>
	<dc:source>10.15294/jstrp.v2i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/sju/JSTRP/article/view/69275/24871</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2023 Journal of Science and Technology Research for Pharmacy</dc:rights>
</oai_dc:dc>